)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Malin
Malin (MLC) investor relations material
Malin H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2026 earnings summary26 Aug, 2026
Executive summary
Intrinsic equity value per share was €9.36 at 30 June 2026, up from €9.21 at 31 December 2025, but fell to €8.28 by 24 August 2026 due to a reduction in Kymab's fair value and lower cash balance.
Cash position was €11.6 million at 30 June 2026, decreasing to €11.2 million by 24 August 2026, reflecting normal operating expenses.
Investee interests are now concentrated in a few areas, with direct involvement reduced following recent divestments and capital returns.
Financial highlights
Intrinsic equity value increased to €40.7 million at 30 June 2026 from €39.9 million at 31 December 2025, mainly due to FX movements and discount rate unwinding.
Corporate cash operating expenses for H1 2026 were €0.8 million.
Intrinsic equity value per share dropped 12% to €8.28 by 24 August 2026, driven by Kymab's fair value reduction and lower cash.
Outlook and guidance
Monitoring of Poseida CVR milestones continues, with potential for further contingent payments.
Kymab contingent consideration reduced to nil after Sanofi discontinued amlitelimab development in July 2026.
Viamet's value could be materially impacted by an FDA review expected in H2 2026.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Malin
- Portfolio of innovative life sciences assets targets near-term value creation and shareholder returns.MLC
Investor presentation - Intrinsic equity value per share increased to €9.24, with major leadership changes and capital return.MLCH2 2025
- Intrinsic equity value was €41.3M on 30 June 2025, with €13.7M in cash.MLCH1 2025
- Cash surges to €62.9m post-CG Oncology sale; €45m capital return planned for shareholders.MLCH1 2024
- Major divestments drove a €150m capital return and record cash reserves for Malin in 2024.MLCH2 2024
Next Malin earnings date
H2 202625 Feb, 2027
Malin
Next Malin earnings date
H2 202625 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Malin Corporation plc is a publicly listed investment company focused on the life sciences sector. The company primarily invests in innovative companies within oncology, immunology, and genetic diseases, aiming to support the development of transformative healthcare technologies. Malin provides long-term capital and strategic support to its investee companies, helping them to achieve their full value potential. Malin Corporation is headquartered in Dublin, Ireland, and its shares are listed on the Euronext Dublin.